Novavax reported $209.29M in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Agenus AGEN:US $ -44972000 8.98M
AstraZeneca AZN:LN 181.11B 36.36B
Astrazeneca AZN:US 2.2B 673M
Biocryst Pharmaceuticals BCRX:US $ -34722000 15.24M
Dynavax Technologies DVAX:US $ 127.67M 96.2M
Genocea Biosciences GNCA:US $ -15773000 2.36M
Geron GERN:US $ -27976000 699K
GlaxoSmithKline GSK:LN 181.6B 5.9B
Mannkind MNKD:US $ -24957000 1.72M
Merk MRK:US $ 5711M 652M
Minerva Neurosciences NERV:US $ -6965190 1.02M
Moderna Inc MRNA:US 2.45B 1.78B
Novartis NVS:US 3.32B 176M
Pain Therapeutics PTIE:US $ -19917000 2.1M
Peregrine Pharmaceuticals PPHM:US $ 2.74M 1.67M
Pfizer PFE:US $ 12099M 2104M
Sarepta Therapeutics SRPT:US $ -211132000 124.25M
Tg Therapeutics TGTX:US $ -38941000 27.93M